Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

The higher dose supplement was more effective in treating female hair loss.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Monitoring for adverse effects in clinical treatments is crucial.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.